Salmon sperm serums surge as influencers and medspas sell a controversial facelift

A wave of salmon sperm skincare has moved from Seoul clinics to U.S. social feeds, propelled most recently by megaviral influencer Mikayla Nogueira announcing a salmon-derived PDRN face ampoule and eye serum to her 17 million followers. The trend has translated into in-clinic offerings across Los Angeles, where medspas now charge $550 at Formula Fig, $750 at Dorfman in Beverly Hills, and $1,000 and up at Kanodia Med Spa for procedures that inject or apply polydeoxyribonucleotide beneath the skin.

PDRN, short for polydeoxyribonucleotide, is “essentially just a DNA fragment,” says cosmetic chemist Victoria Fu of Chemist Confessions, and the ingredient has historically been sourced from human placenta before the industry shifted toward salmon and trout sperm. Proponents say PDRN stimulates cell regeneration, boosts collagen production, calms irritation and speeds healing, claims that help explain clinicians’ interest in the ingredient for scarring, fine lines and dull, dry skin.

The route of delivery matters. “The short answer is no, but that doesn't mean you shouldn't consider incorporating PDRN into your skincare routine,” one summary put it, noting topical serums are unlikely to penetrate the top layer of skin deeply enough to trigger the full reparative response. Rob Knight, lead scientist at AnteAGE, says trout and salmon sperm are “remarkably similar to human DNA,” and points to products such as AnteAGE’s P.E.A.R.L Advanced Cell Signaling System, which “contains PDRN and exosomes, and is applied to skin after radio frequency microneedling.” Clinician-led treatments typically pair PDRN with ablative or microneedling procedures so the ingredient can reach receptive tissue below the epidermis.

Yet the in-clinic injections have regulatory and recovery caveats. The injected salmon sperm facial “isn't FDA-approved in the U.S.,” a point that has helped spur a market for topical PDRN serums, lab-grown analogs and vegan alternatives. Uniproma GmbH now advertises lab-grown PDRN that it says is molecularly identical to salmon DNA, and Epoch Dermatology owner Nicole Lee, MD, notes there are “vegan PDRN options extracted from plants, such as algae,” while cautioning that performance “depends heavily on the formulation and concentration.”

Patient reports illustrate the trade-offs. One clinic patient described the procedure as painful, saying “It was painful, just because it’s salmon semen essentially going under your eye,” and reported under-eye bruising that “turned purple, and then it turned yellow” for about a week. Other users report less dramatic recovery. Shirel Swissa, who routinely microneedles, said, “Right now, my skin is the smoothest and clearest it’s been in forever. There’s no texture. It also helps with my active acne.” On the scent she added, “It smells a tiny bit fishy. It’s not overpowering, but it’s tolerable.”

The commercial pitch is emphatic. Nogueira’s launch copy promises “a science-backed duo powered by PDRN that is going to lift, firm, plump your skin plus so much more,” and highlights Korean manufacture and clinical testing. Dermatologists and chemists urge caution: clinical claims vary, peer-reviewed study details remain sparse in public marketing, and efficacy appears tied to delivery method, concentration and formulation.

“It’s an exploding field,” said Dr. Yoo, while advising skepticism as the market expands. For consumers, the immediate decisions are tangible: pay several hundred to more than a thousand dollars for an in-clinic procedure with a week of possible downtime, try newly marketed topical serums of uncertain penetration, or wait for more published clinical data and clearer regulatory guidance.